Nuveen’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $880K | Buy |
106,047
+669
| +0.6% | +$6.93K | ﹤0.01% | 2634 |
|
|
2025
Q4 | $1.3M | Sell |
105,378
-8,761
| -8% | -$93.9K | ﹤0.01% | 2481 |
|
|
2025
Q3 | $1.01M | Sell |
114,139
-177,597
| -61% | -$1.38M | ﹤0.01% | 2625 |
|
|
2025
Q2 | $1.86M | Buy |
+291,736
| New | +$1.67M | ﹤0.01% | 2337 |
|
|
2024
Q2 | – | Sell |
-56,201
| Closed | -$142K | – | 3359 |
|
|
2024
Q1 | $142K | Hold |
56,201
| – | – | ﹤0.01% | 3226 |
|
|
2023
Q4 | $135K | Hold |
56,201
| – | – | ﹤0.01% | 3260 |
|
|
2023
Q3 | $191K | Hold |
56,201
| – | – | ﹤0.01% | 3046 |
|
|
2023
Q2 | $413K | Sell |
56,201
-80,994
| -59% | -$751K | ﹤0.01% | 2958 |
|
|
2023
Q1 | $1.42M | Sell |
137,195
-11,506
| -8% | -$139K | ﹤0.01% | 2473 |
|
|
2022
Q4 | $1.76M | Sell |
148,701
-22,275
| -13% | -$345K | ﹤0.01% | 2448 |
|
|
2022
Q3 | $3.59M | Sell |
170,976
-2,064
| -1% | -$57.4K | ﹤0.01% | 2087 |
|
|
2022
Q2 | $5.37M | Sell |
173,040
-4,267
| -2% | -$146K | ﹤0.01% | 1896 |
|
|
2022
Q1 | $7.36M | Sell |
177,307
-18,897
| -10% | -$833K | ﹤0.01% | 1834 |
|
|
2021
Q4 | $8.53M | Sell |
196,204
-15,234
| -7% | -$689K | ﹤0.01% | 1795 |
|
|
2021
Q3 | $10.6M | Sell |
211,438
-114,521
| -35% | -$6.94M | ﹤0.01% | 1739 |
|
|
2021
Q2 | $20.5M | Sell |
325,959
-81,025
| -20% | -$5.21M | 0.01% | 1344 |
|
|
2021
Q1 | $37.8M | Buy |
406,984
+41,594
| +11% | +$4.26M | 0.01% | 886 |
|
|
2020
Q4 | $32.7M | Buy |
365,390
+54,087
| +17% | +$4.96M | 0.01% | 930 |
|
|
2020
Q3 | $32.2M | Buy |
311,303
+27,821
| +10% | +$3M | 0.01% | 782 |
|
|
2020
Q2 | $22.4M | Buy |
283,482
+16,686
| +6% | +$1.24M | 0.01% | 966 |
|
|
2020
Q1 | $15.4M | Buy |
266,796
+31,481
| +13% | +$1.81M | 0.01% | 1034 |
|
|
2019
Q4 | $12.7M | Buy |
235,315
+47,912
| +26% | +$2.6M | ﹤0.01% | 1442 |
|
|
2019
Q3 | $9.8M | Sell |
187,403
-13,443
| -7% | -$626K | ﹤0.01% | 1586 |
|
|
2019
Q2 | $9.7M | Buy |
200,846
+170,018
| +552% | +$8.15M | ﹤0.01% | 1631 |
|
|
2019
Q1 | $1.56M | Buy |
30,828
+6,545
| +27% | +$386K | 0.01% | 670 |
|
|
2018
Q4 | $1.44M | Sell |
24,283
-11,516
| -32% | -$742K | 0.01% | 655 |
|
|
2018
Q3 | $2.36M | Sell |
35,799
-19,802
| -36% | -$1.16M | 0.01% | 630 |
|
|
2018
Q2 | $2.81M | Buy |
55,601
+3,125
| +6% | +$163K | 0.02% | 573 |
|
|
2018
Q1 | $2.76M | Buy |
52,476
+5,387
| +11% | +$268K | 0.02% | 563 |
|
|
2017
Q4 | $2.19M | Sell |
47,089
-8,365
| -15% | -$352K | 0.01% | 588 |
|
|
2017
Q3 | $2.24M | Sell |
55,454
-16,019
| -22% | -$580K | 0.01% | 597 |
|
|
2017
Q2 | $2.42M | Buy |
71,473
+7,286
| +11% | +$225K | 0.02% | 594 |
|
|
2017
Q1 | $1.86M | Buy |
64,187
+4,440
| +7% | +$135K | 0.01% | 723 |
|
|
2016
Q4 | $1.96M | Sell |
59,747
-2,401
| -4% | -$72K | 0.01% | 892 |
|
|
2016
Q3 | $1.96M | Buy |
62,148
+3,189
| +5% | +$92.7K | 0.01% | 796 |
|
|
2016
Q2 | $1.66M | Sell |
58,959
-1,726
| -3% | -$67.7K | 0.01% | 830 |
|
|
2016
Q1 | $2.21K | Buy |
60,685
+2,785
| +5% | +$98.4K | 0.01% | 701 |
|
|
2015
Q4 | $2.32K | Buy |
57,900
+8,586
| +17% | +$299K | 0.01% | 715 |
|
|
2015
Q3 | $1.41K | Buy |
49,314
+28,681
| +139% | +$945K | 0.01% | 935 |
|
|
2015
Q2 | $680 | Buy |
+20,633
| New | +$640K | ﹤0.01% | 1288 |
|
Other funds holding EBS
VCM
PCM
VPM